Non-Hodgkin's malignant lymphomas: treatment of localized relapses with chemo + radio + BCG-therapy

Oncology. 1982;39(5):292-4. doi: 10.1159/000225654.


16 patients with relapsing non-Hodgkin's malignant lymphomas considered as clinical stage I or II were treated by an association of chemo + radiotherapy and thereafter by maintenance BCG therapy. 5 of them were included in a randomized trial and have a significantly different disease-free survival from patients receiving the same treatment but without BCG. 11 were systematically treated by BCG and they also have a fairly good disease-free survival. Such a treatment appears to be of value in treating these patients and even probably of curing some of them.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use*
  • BCG Vaccine / therapeutic use*
  • Clinical Trials as Topic
  • Female
  • Humans
  • Lymphoma / drug therapy
  • Lymphoma / radiotherapy
  • Lymphoma / therapy*
  • Male
  • Middle Aged
  • Random Allocation


  • Antineoplastic Agents
  • BCG Vaccine